<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02624648</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 43373915.3.0000.5479</org_study_id>
    <nct_id>NCT02624648</nct_id>
  </id_info>
  <brief_title>Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women</brief_title>
  <acronym>maca</acronym>
  <official_title>Effects of Lepidium Meyenii Walp (Peruvian Maca) on Sexual Function in Postmenopausal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade do Vale do Sapucai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irmandade da Santa Casa de Misericordia de Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade do Vale do Sapucai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To study the effects of Lepidium Meyenii in sexual function of postmenopausal
      women.

      Method: It will be held a clinical, prospective, randomized, double-blind, placebo-controlled
      study with 144 postmenopausal women with sexual dysfunction, treated at Menopause Clinic at
      the Faculty of Medical Sciences of Santa Casa de São Paulo and in the Vale do Sapucai
      University. All women sign the Consent Form Term. The study will be conducted in accordance
      with the protocol and principles of the Declaration Helsinki (Version 1996), according to
      International Conference on Harmonization and Tripartite Guidelines for good clinical
      practice and regulatory requirements. The protocol was approved by the Ethics Committee of
      the Faculty of Medical Sciences of Santa Casa de São Paulo.

      Hypothesis: It is expected to be an improvement of sexual function in postmenopausal women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It will be a prospective, randomized, double-blind, placebo-controlled study with 144
      postmenopausal women with sexual dysfunction, met in Menopause Clinic at the Faculty of
      Medical Sciences of Santa Casa de São Paulo and in the Vale do Sapucai University. All women
      signed the Informed Consent. The study will be conducted in accordance with the protocol and
      principles set out in Declaration of Helsinki (1996 version), according to International
      Conference on Harmonization and Tripartite Guidelines for good practice clinics and
      applicable regulatory requirements.

      The protocol was submitted and approved by the Ethics Committee, Faculty of Medical Sciences
      Committee Santa Casa de São Paulo. The diagnosis of sexual dysfunction will be done by a
      sexologist physician experienced and trained in the diagnosis of female sexual disorders
      through a structured clinical interview, a list of sexual symptoms. It will be oriented to
      avoid further consumption of diet or another type of herbal medicine during the study. After
      the interview, signing the Informed Consent and they will be informed about the
      randomization. Interview with sexological questionnaires will be applied used in Sexology
      Clinic, Faculty of Medical Sciences of Santa Casa de São Paulo and Vale do Sapucai
      University, with the purpose of obtaining data sociodemographic. The Female Sexual function
      Index (FSFI) and the Female Intervention Efficacy Index questionnaire (FIEI). When necessary,
      the Beck Depression Inventory II (Cunha 2001) will be used to ward off depression, which will
      be applied by enabled professional. The application will be individually and by the same
      researcher. The results will be analyzed and interpreted in the light of the theoretical
      framework of socio-historical psychology, this theory of knowledge, is associated with the
      understanding of the culture of the structure, social organization and the rescue human
      subjectivity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FSFI Questionnaire to evaluate the sexual function</measure>
    <time_frame>120 days</time_frame>
    <description>To study the effects of Lepidium meyenii and placebo on sexual function in postmenopausal women</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FIEI Questionnaire to evaluate the sexual desire</measure>
    <time_frame>120 days</time_frame>
    <description>To study the effects of Lepidium meyenii and placebo on sexual desire in postmenopausal women</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The Beck Depression Inventory II to evaluate depression</measure>
    <time_frame>120 days</time_frame>
    <description>It will be used to evaluate or ward off depression</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Sexual Dysfunction, Physiological</condition>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The effects of Placebo on sexual function, desire and depression in postmenopausal women.
The Female Sexual Function Index (FSFI) and the Female Intervention Efficacy Index Questionnaire (FIEI).
The Beck Depression Inventory II will be used to ward off depression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maca (Lepidium Meyenii Walp) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The effects of Lepidium Meyenii Walp on sexual function, desire and depression in postmenopausal women.
The Female Sexual Function Index (FSFI) and the Female Intervention Efficacy Index Questionnaire (FIEI).
The Beck Depression Inventory II will be used to ward off depression</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Female Sexual Function Index (FSFI)</intervention_name>
    <description>The Female Sexual Function Index (FSFI) Questionnaire to evaluate the sexual function</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_label>Maca (Lepidium Meyenii Walp) Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Female Intervention Efficacy Index (FIEI)</intervention_name>
    <description>The Female Intervention Efficacy Index Questionnaire (FIEI) to evaluate the sexual function</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_label>Maca (Lepidium Meyenii Walp) Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Beck Depression Inventory II</intervention_name>
    <description>The Beck Depression Inventory II will be used to evaluate or ward off depression</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_label>Maca (Lepidium Meyenii Walp) Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lepidium Meyenii Walp</intervention_name>
    <description>They will receive a capsule of Lepidium Meyenii Walp twice a day for 120 days</description>
    <arm_group_label>Maca (Lepidium Meyenii Walp) Group</arm_group_label>
    <other_name>Maca</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>They will receive a capsule of Placebo twice a day for 120 days</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The postmenopausal women with full autonomy, with one year or more of amenorrhea and
             follicle stimulating hormone (FSH) &gt; 30 milli-International unit/mL

          -  Women who are not regularly practicing sexual activity will be included because the
             desire domain is subject to the same evaluation in this situation

          -  Estrogen and progesterone were permitted if the dose had been stable for six months
             prior to screening

        Exclusion Criteria:

          -  Cardiac, renal and hepatic diseases

          -  Diabetes mellitus

          -  Cognitive disorders

          -  Hormone-dependent tumor

          -  History of psychiatric illness current and/or past, regular use of two or more doses
             of alcohol by day (dose = 12 grams of pure alcohol, which corresponds to 330 mL of
             beer, 100 mL wine, 30 mL of distilled World Health Organization standard dose) leading
             to impairment or clinically significant distress (DSM-5)

          -  Consumption of Maca supplements or any other nutritional supplement known to cause
             changes in sexual function

          -  Use of any drug that, in the opinion of the investigator, may affect sexual function
             or any of the following medications: anti-epileptics, cytochrome P450 isoform 3A4
             (CYP3A4) inducers

          -  Dopamine agonists and other parkinsonian drugs

          -  Metoclopramide

          -  Androgens and antiandrogens, the anti-oestrogens

          -  Fluoxetine or any hormonal implant long-acting in 30 days before the exam

          -  Analogues of gonadotropin-releasing hormone and other hormones and inhibitors

          -  Benzodiazepines prescribed for insomnia

          -  Sedatives and hypnotics

          -  Antidepressants

          -  Antipsychotics, mood stabilizers, narcotics (except when used to relieve short-term
             pain),

          -  Lubricants/moisturizers that contain substances that promote heating and/or vaginal
             stimulators
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabiola SM Campos, MD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade do Vale do Sapucai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sonia Maria R Rosa Lima, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa of São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BENEDITO FABIANO D REIS, PhD</last_name>
    <phone>553534730942</phone>
    <email>benefabiano@uol.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gustavo Maximiliano D Silva, MD</last_name>
    <phone>5511994192039</phone>
    <email>gumaxy@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vale Do Sapucai University (Univas)</name>
      <address>
        <city>Pouso Alegre</city>
        <state>MG</state>
        <zip>37550-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BENEDITO F REIS, PROF</last_name>
      <phone>553599844648</phone>
      <email>benefabiano@uol.com.br</email>
    </contact>
    <contact_backup>
      <last_name>SONIA MARIA R ROSA LIMA, PROF</last_name>
      <phone>5511971519229</phone>
      <email>lima@silber.com.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Dailey RK, Neale AV, Northrup J, West P, Schwartz KL. Herbal product use and menopause symptom relief in primary care patients: a MetroNet study. J Womens Health (Larchmt). 2003 Sep;12(7):633-41.</citation>
    <PMID>14583104</PMID>
  </results_reference>
  <results_reference>
    <citation>Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt). 2005 Sep;14(7):634-49. Review.</citation>
    <PMID>16181020</PMID>
  </results_reference>
  <results_reference>
    <citation>Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002 Nov 19;137(10):805-13. Review.</citation>
    <PMID>12435217</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Sluijs CP, Bensoussan A, Liyanage L, Shah S. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause. 2007 May-Jun;14(3 Pt 1):397-403.</citation>
    <PMID>17202872</PMID>
  </results_reference>
  <results_reference>
    <citation>Minelli C, Abrams KR, Sutton AJ, Cooper NJ. Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ. 2004 Feb 14;328(7436):371.</citation>
    <PMID>14962874</PMID>
  </results_reference>
  <results_reference>
    <citation>Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med. 2005 Dec 19;118 Suppl 12B:98-108. Review.</citation>
    <PMID>16414334</PMID>
  </results_reference>
  <results_reference>
    <citation>Chung F, Rubio J, Gonzales C, Gasco M, Gonzales GF. Dose-response effects of Lepidium meyenii (Maca) aqueous extract on testicular function and weight of different organs in adult rats. J Ethnopharmacol. 2005 Apr 8;98(1-2):143-7.</citation>
    <PMID>15763375</PMID>
  </results_reference>
  <results_reference>
    <citation>Meissner HO, Kapczynski W, Mscisz A, Lutomski J. Use of gelatinized maca (lepidium peruvianum) in early postmenopausal women. Int J Biomed Sci. 2005 Jun;1(1):33-45.</citation>
    <PMID>23674952</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Cordova A, Gonzales C, Chung A, Vega K, Villena A. Lepidium meyenii (Maca) improved semen parameters in adult men. Asian J Androl. 2001 Dec;3(4):301-3.</citation>
    <PMID>11753476</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Ruiz A, Gonzales C, Villegas L, Cordova A. Effect of Lepidium meyenii (maca) roots on spermatogenesis of male rats. Asian J Androl. 2001 Sep;3(3):231-3.</citation>
    <PMID>11561196</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Córdova A, Vega K, Chung A, Villena A, Góñez C, Castillo S. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. 2002 Dec;34(6):367-72.</citation>
    <PMID>12472620</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Córdova A, Vega K, Chung A, Villena A, Góñez C. Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J Endocrinol. 2003 Jan;176(1):163-8.</citation>
    <PMID>12525260</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Gasco M, Córdova A, Chung A, Rubio J, Villegas L. Effect of Lepidium meyenii (Maca) on spermatogenesis in male rats acutely exposed to high altitude (4340 m). J Endocrinol. 2004 Jan;180(1):87-95.</citation>
    <PMID>14709147</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Miranda S, Nieto J, Fernández G, Yucra S, Rubio J, Yi P, Gasco M. Red maca (Lepidium meyenii) reduced prostate size in rats. Reprod Biol Endocrinol. 2005 Jan 20;3:5.</citation>
    <PMID>15661081</PMID>
  </results_reference>
  <results_reference>
    <citation>Oshima M, Gu Y, Tsukada S. Effects of Lepidium meyenii Walp and Jatropha macrantha on blood levels of estradiol-17 beta, progesterone, testosterone and the rate of embryo implantation in mice. J Vet Med Sci. 2003 Oct;65(10):1145-6.</citation>
    <PMID>14600359</PMID>
  </results_reference>
  <results_reference>
    <citation>Zheng BL, He K, Kim CH, Rogers L, Shao Y, Huang ZY, Lu Y, Yan SJ, Qien LC, Zheng QY. Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology. 2000 Apr;55(4):598-602.</citation>
    <PMID>10736519</PMID>
  </results_reference>
  <results_reference>
    <citation>Cicero AF, Bandieri E, Arletti R. Lepidium meyenii Walp. improves sexual behaviour in male rats independently from its action on spontaneous locomotor activity. J Ethnopharmacol. 2001 May;75(2-3):225-9.</citation>
    <PMID>11297856</PMID>
  </results_reference>
  <results_reference>
    <citation>Ruiz-Luna AC, Salazar S, Aspajo NJ, Rubio J, Gasco M, Gonzales GF. Lepidium meyenii (Maca) increases litter size in normal adult female mice. Reprod Biol Endocrinol. 2005 May 3;3:16.</citation>
    <PMID>15869705</PMID>
  </results_reference>
  <results_reference>
    <citation>Valentová K, Buckiová D, Kren V, Peknicová J, Ulrichová J, Simánek V. The in vitro biological activity of Lepidium meyenii extracts. Cell Biol Toxicol. 2006 Mar;22(2):91-9. Epub 2006 Mar 9.</citation>
    <PMID>16528448</PMID>
  </results_reference>
  <results_reference>
    <citation>Bogani P, Simonini F, Iriti M, Rossoni M, Faoro F, Poletti A, Visioli F. Lepidium meyenii (Maca) does not exert direct androgenic activities. J Ethnopharmacol. 2006 Apr 6;104(3):415-7. Epub 2005 Oct 18.</citation>
    <PMID>16239088</PMID>
  </results_reference>
  <results_reference>
    <citation>Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004 Jan;61(1):62-70.</citation>
    <PMID>14706945</PMID>
  </results_reference>
  <results_reference>
    <citation>Rubio J, Caldas M, Dávila S, Gasco M, Gonzales GF. Effect of three different cultivars of Lepidium meyenii (Maca) on learning and depression in ovariectomized mice. BMC Complement Altern Med. 2006 Jun 23;6:23.</citation>
    <PMID>16796734</PMID>
  </results_reference>
  <results_reference>
    <citation>Bosworth HB, Bastian LA, Kuchibhatla MN, Steffens DC, McBride CM, Skinner CS, Rimer BK, Siegler IC. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med. 2001 Jul-Aug;63(4):603-8.</citation>
    <PMID>11485114</PMID>
  </results_reference>
  <results_reference>
    <citation>Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res. 2003;14:64-82. Review.</citation>
    <PMID>15287158</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzales GF, Gonzales C, Gonzales-Castañeda C. Lepidium meyenii (Maca): a plant from the highlands of Peru--from tradition to science. Forsch Komplementmed. 2009 Dec;16(6):373-80. doi: 10.1159/000264618. Epub 2009 Dec 16. Review.</citation>
    <PMID>20090350</PMID>
  </results_reference>
  <results_reference>
    <citation>Berman LA, Berman JR, Werbin T, Chabra S, Goldstein I. The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction. J Sex Marital Ther. 2001 Oct-Dec;27(5):427-33.</citation>
    <PMID>11554203</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>December 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2015</study_first_posted>
  <last_update_submitted>June 19, 2016</last_update_submitted>
  <last_update_submitted_qc>June 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade do Vale do Sapucai</investigator_affiliation>
    <investigator_full_name>Benedito Fabiano dos Reis</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Sexual Dysfunction</keyword>
  <keyword>Postmenopausal women</keyword>
  <keyword>Sexual desire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sexual Dysfunction, Physiological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

